Active Ingredient(s):Isavuconazonium Sulfate FDA Approved: * March 6, 2015 Pharm Company: *ASTELLAS Category:Antifungal
Isavuconazonium sulfate, sold under the brand name Cresemba, is a systemic antifungal medication of the triazole class which is used to treat invasive aspergillosis and mucormycosis.
The most common side effects include abnormal liver tests, nausea, vomiting, difficulty breathing, abdominal pain, diarrhea, injection site reactions, headache, low blood potassium and skin rash.
Isavuconazonium is a pr...
* May have multiple approval dates, manufacturers, or labelers.